{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:34:47Z","timestamp":1766208887756,"version":"3.48.0"},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.2169\/internalmedicine.4267-24","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:34Z","timestamp":1749060454000},"page":"3569-3576","source":"Crossref","is-referenced-by-count":1,"title":["Disseminated Nontuberculous Mycobacterial Infection Following Cerebral Shunt Infection Caused by &lt;i&gt;Mycobacterium fortuitum&lt;\/i&gt;: A Case Report and Literature Review"],"prefix":"10.2169","volume":"64","author":[{"given":"Mio","family":"Toyama-Kousaka","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shinoda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Fujisaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagashige","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Shinkai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Park S, Suh GY, Chung MP, et al. Clinical significance of <i>Mycobacterium fortuitum<\/i> isolated from respiratory specimens. Respir Med 102: 437-442, 2008.","DOI":"10.1016\/j.rmed.2007.10.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zweijipfenning SMH, Ingen JV, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review. Semin Respir Crit Care Med 39: 336-342, 2018.","DOI":"10.1055\/s-0038-1660864"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Franco-Paredes C, Marcos LA, Henao-Martinez AF, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev 32: e00069-18, 2018.","DOI":"10.1128\/CMR.00069-18"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kumar C, Shivastava K, Singh A, Chauhan V, Varma-Basil M. Skin and soft-tissue infections due to rapidly growing mycobacteria: an overview. Int J Mycobcteriol 10: 293-300, 2021.","DOI":"10.4103\/ijmy.ijmy_110_21"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Griffth DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007.","DOI":"10.1164\/rccm.200604-571ST"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rimmer J, Hamilton S, Gault D. Recurrent mycobacterial breast abscesses complicating reconstruction. Br J Plast Surg 57: 676, 2004.","DOI":"10.1016\/j.bjps.2004.06.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hall-Stoodley L, Lappin-Scott H. Biofilm formation by the rapidly growing mycobacterial species <i>Mycobacterium fortuitum<\/i>. FEMS Microbiol Lett 168: 77-84, 1998.","DOI":"10.1111\/j.1574-6968.1998.tb13258.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Esteban J, Martin-de-Hijas NZ, Kinnari T, Ayala G, Fernandez-Roblas R, Gadea I. Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria. BMC Microbiol 8: 184, 2008.","DOI":"10.1186\/1471-2180-8-184"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. El Helou G, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13: 166-174, 2013.","DOI":"10.1016\/S1473-3099(12)70316-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yazidi LSA, Marais BJ, Hazelton B, Outhred A, Kesson A. Nontuberculous mycobacteria in children: a focus on bloodstream infections. Pediatr Infect Dis J 36: 374-378, 2017.","DOI":"10.1097\/INF.0000000000001448"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis 45: 687-694, 2007.","DOI":"10.1086\/520982"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Washida N, Itoh H. The role of non-tuberculous mycobacteria in peritoneal dialysis-related infections: a literature review. Contrib Nephrol 196: 155-161, 2018.","DOI":"10.1159\/000485716"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shabi Y, Haldane D, Bonnar P. <i>Mycobacterium fortuitum<\/i> pacemaker infection: a case report. J Assoc Med Microbiol Infect Dis Can 7: 81-83, 2022.","DOI":"10.3138\/jammi-2021-0003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Smith MB, Schnadig VJ, Boyars MC, Woods GL. Clinical and pathologic features of <i>Mycobacterium fortuitum<\/i> infections. An emerging pathogen in patients with AIDS. Am J Clin Pathol 116: 225-232, 2001.","DOI":"10.1309\/HF2V-E8WV-PX4Q-CHQH"},{"key":"15","unstructured":"15. Reddy VCK, Prasad CE, Aparna S, Gokhale S, Anjeneyulu. A study of mycobacterial species causing lymphadenitis. Southeast Asian J Trop Med Public Health 39: 130-135, 2008."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rodriguez-Barradas MC, Clarridge J, Darouiche R. Disseminated <i>Mycobacterium fortuitum<\/i> disease in an AIDS patient. Am J Med 93: 473-474, 1992.","DOI":"10.1016\/0002-9343(92)90182-B"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Redelman-Sidi G, Sepkowitz KA. Rapidly growing mycobacteria infection in patients with cancer. Clin Infect Dis 51: 422-434, 2010.","DOI":"10.1086\/655140"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious diseases Society of America&apos;s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 64: e34-e65, 2017.","DOI":"10.1093\/cid\/ciw861"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Seidelman J, Lewis SS. Neurosurgical device-related infections. Infect Dis Clin North Am 32: 861-876, 2018.","DOI":"10.1016\/j.idc.2018.06.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Al-Sharydah AM, Abu Melha YA, Al-Suhibani SS, et al. Rates of cerebrospinal fluid infection and the causative organisms following shunt procedures in Saudi Arabia. A retrospective study based on radiological findings. Saudi Med J 41: 607-613, 2020.","DOI":"10.15537\/smj.2020.6.25095"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zeggay A, Patry I, Chirouze C. Characteristics and outcomes of cerebrospinal fluid shunt and drain-associated infections. Infect Dis Now 53: 104665, 2023.","DOI":"10.1016\/j.idnow.2023.104665"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hasbun R. Central nervous system device infections. Curr Infect Dis Rep 18: 34, 2016.","DOI":"10.1007\/s11908-016-0541-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lattanzio N, Bell S, Campdesuner V, et al. <i>Mycobacterium fortuitum<\/i> ventriculoperitoneal shunt infection in an immunocompromised patient: a case report. ID Cases 22: e00995, 2020.","DOI":"10.1016\/j.idcr.2020.e00995"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dash A, Gupta N, Ray Y, Kodan P, Singh BK, Soneja M. Choosing the therapy for neurological infection with rapidly growing mycobacteria. Drug Discov Ther 14: 211-212, 2020.","DOI":"10.5582\/ddt.2020.03026"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Padmanaban V, Hussein R, Rick E. Nontuberculous mycobacterial infection in patients with neurosurgical hardware: two cases and a review of the literature. Cureus 12: e7398, 2020.","DOI":"10.7759\/cureus.7398"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zakrzewski J, Hu K, Neisewander BL, et al. <i>Mycobacterium fortuitum<\/i> meningitis: approach to lumboperitoneal shunt infection. South Med J 112: 217-221, 2019.","DOI":"10.14423\/SMJ.0000000000000955"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Xess AB, Bala K, Panigrahy A, Singh U. <i>Mycobacterium fortuitum<\/i> as a cause of acute CNS infection in an immune-competent girl undergoing repeated VP shunt surgeries. BMJ Case Rep 12: e226900, 2019.","DOI":"10.1136\/bcr-2018-226900"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cadena G, Wiedeman J, Boggan JE. Ventriculoperitoneal shunt infection with <i>Mycobacterium fortuitum<\/i>: a rare offending organism. J Neurosurg Pediatr 14: 704-707, 2014.","DOI":"10.3171\/2014.8.PEDS13677"},{"key":"29","unstructured":"29. Viswanathan R, Bhagwati SN, Iyer V, Newalkar P. Ventriculo-peritoneal shunt infection by <i>Mycobacterium fortuitum<\/i> in an adult. Neurol India 52: 393-394, 2004."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Quinn JV, Steele RW. Ventriculitis following a neurosurgic procedure. Clin Pediatr (Phila) 41: 439-441, 2002.","DOI":"10.1177\/000992280204100610"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Midani S, Rathore MH. <i>Mycobacterium fortuitum<\/i> infection of ventriculoperitoneal shunt. South Med J 92: 705-707, 1999.","DOI":"10.1097\/00007611-199907000-00009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Chan KH, Mann KS, Seto WH. Infection of a shunt by <i>Mycobacterium fortuitum<\/i>: case report. Neurosurgery 29: 472-474, 1991.","DOI":"10.1227\/00006123-199109000-00028"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 367: 725-734, 2012.","DOI":"10.1056\/NEJMoa1111160"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Aoki A, Sakagami T, Yoshizawa K, et al. Cliniacal significance of interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease. Clin Infect Dis 66: 1239-1245, 2018.","DOI":"10.1093\/cid\/cix996"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Talati NJ, Rouphael N, Kuppallo K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis 8: 390-398, 2008.","DOI":"10.1016\/S1473-3099(08)70127-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Lange C, Bottger EC, Cambau E, et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis 22: e178-e190, 2022.","DOI":"10.1016\/S1473-3099(21)00586-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Nash KA, Zhang Y, Brown-Elliott BA, Wallace Jr RJ. Molecular basis of intrinsic macrolide resistance on clinical isolated of <i>Mycobacterium fortuitum<\/i>. J Antimicrob Chemother 55: 170-177, 2005.","DOI":"10.1093\/jac\/dkh523"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 16: 463-471, 1993.","DOI":"10.1093\/clind\/16.4.463"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nau R, Sorgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23: 858-883, 2010.","DOI":"10.1128\/CMR.00007-10"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/24\/64_4267-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T03:39:43Z","timestamp":1766201983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/24\/64_4267-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":39,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4267-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"4267-24"}}